Prefabrication of vascularized porous three-dimensional scaffold induced from rhVEGF165: A preliminary study in rats

Cells Tissues Organs

Volumn 189, Issue 5, 2009, Pages 327-337

  Yang, Pei ^a   Wang, Chunsheng ^a   Shi, Zhibin ^a   Huang, Xin ^a   Dang, Xiaoqian ^a   Xu, Shanglong ^b   Wang, Kunzheng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Scaffolds, prefabrication; Tissue engineering; Vascular endothelial growth factor

Indexed keywords

CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CEMENT SCAFFOLD; CEMENT; FIBRIN GLUE; PLASMIN; RECOMBINANT GROWTH FACTOR; RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR 165; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN 165;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOGENOUS VASCULARIZED BONE GRAFT; AUTOGRAFT; BLOOD VESSEL DIAMETER; BLOOD VESSEL FUNCTION; BONE GRAFT; CONTROLLED STUDY; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; TISSUE SECTION; VASCULARIZATION;

ANIMALS; BONE SUBSTITUTES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 64349098874     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142162     Document Type: Article

References (38)

1. Alon, T., I. Hemo, A. Itin, J. Pe'er, J. Stone, E. Kes-het (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for reti-nopathy of prematurity. Nat Med 10: 1024-1028.
2. Celik, M., S. Tuncer, U. Emekli, S.N. Kesim (2000) Histologic analysis of prefabricated, vascularized bone grafts: an experimental study in rabbits. J Oral Maxillofac Surg 58: 292-295.
3. Chen, Z.Z., D.C. Li, B.H. Lu, Y.P. Tang, MX. Sun, Z. Wang (2004) Fabrication of artificial bio-active bone using rapid prototyping. Rapid Prototyping J 10: 327-333.
4. Clarke, S.A., N.L. Hoskins, G.R. Jordan, D.R. Marsh (2007) Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX, in association with autologous osteo-genic cells and growth factors. Bone 40: 939-947.
5. Comuzzi, L., E. Ooms, J.A. Jansen (2002) Intertable calcium phosphate cement as a filler for bone defects around oral implants: an experimental study in goats. Clin Oral Implants Res 13: 304-311.
6. den Boer, F.C., B.W. Wippermann, T.J. Blokhuis, P. Patka, F.C. Bakker, H.J. Haarman (2003) Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic pro-tein-1 or autologous bone marrow. J Orthop Res 21: 521-528.
7. Engsig, M.T., Q.J. Chen, T.H. Vu, A.C. Pedersen, B. Therkidsen, L.R. Lund, K. Henriksen, T. Lenhard, N.T. Foged, Z. Werb, J.M. Delaisse (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151: 879-889.
8. Ferrara, N., T. Davis-Smyth (1997) The biology of vascular endothelial growth factor. En-docr Rev 18: 4-25.
9. Fiedler, J., F. Leucht, J. Waltenberger, C. Dehio, R.E. Brenner (2005) VEGF-A and P1GF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Bio-phys Res Commun 334: 561-568.
10. Geiger, F., H. Bertram, I. Berger, H. Lorenz, O. Wall, C. Eckhardt, H.G. Simank, W. Richter (2005) Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20: 2028-2035.
11. Gerber, H.P., F. Condorelli, J. Park, N. Ferrara (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/ KDR, is up-regulated by hypoxia. J Biol Chem 272: 23659-23667.
12. Giardino, R., N. Nicoli Aldini, M. Fini, M.C. Tanzi, S. Fare, L. Draghi, A. Carpi, A. Nico-lini, G. Giavaresi (2006) Bioabsorbable scaffold for in situ bone regeneration. Biomed Pharmacother 60: 386-392.
13. Greenwald, A.S., S.D. Boden, V.M. Goldberg, Y. Khan, C.T. Laurencin, R.N. Rosier, American Academy of Orthopaedic Surgeons, The Committee on Biological Implants (2001) Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am 83-A: 98-103.
14. Harris, L.D., B.S. Kim, D.J. Mooney (1998) Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 42: 396-402.
15. Hu, Y., C. Zhang, S. Zhang, Z. Xiong, J. Xu (2003) Development of a porous poly(L-lactic acid)/ hydroxyapatite/collagen scaffold as a BMP delivery system and its use in healing canine segmental bone defect. J Biomed Mater Res A 67: 591-598.
16. Hulbert, S.F., S.J. Morrison, T.J. Klawitter (1972) Tissue reaction to three ceramics of porous and non-porous structures. J Biomed Mater Res 6: 347-374.
17. Kaushiva, A., V.M. Turzhitsky, V Backman, G.A. Ameer (2007) A biodegradable vascu-larizing membrane: a feasibility study. Acta Biomater 3: 631-642.
18. Kleinheinz, J., U. Stratmann, U. Joos, H.P. Wies-mann (2005) VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg 63: 1310-1316.
19. Lee, W.K., T. Ichi, T. Ooya, T. Yamamoto, M. Ka-toh, N. Yui (2003) Novel poly(ethylene glycol) scaffolds crosslinked by hydrolyzable polyrotaxane for cartilage tissue engineering. J Biomed Mater Res A 67: 1087-1092.
20. Levy, Y., M. Zilberman (2006) Novel bioresorb-able composite fiber structures loaded with proteins for tissue regeneration applications: microstructure and protein release. J Biomed Mater Res A 79: 779-787.
21. Lo, H., S. Kadiyala, S.E. Guggino, K.W. Leong (1996) Poly(L-lactic acid) foams with cell seeding and controlled-release capacity. J Biomed Mater Res 30: 475-484.
22. Lode, A., C. Wolf-Brandstetter, A. Reinstorf A. Bernhardt, U. Konig, W. Pompe, M. Gelin-sky (2006) Calcium phosphatebone cements, functionalized with VEGF: release kinetics and biological activity. J Biomed Mater Res A 81A: 474-483.
23. Mayr-Wohlfart, U., J. Waltenberger, H. Hausser, S. Kessler, K.P. Gunther, C. Dehio, W. Puhl, R.E. Brenner (2002) Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30: 472-477.
24. Nakagawa, M., T. Kaneda, T. Arakawa, S. Mo-rita, T. Sato, T. Yomada, K. Hanada, M. Kumegawa, Y. Hakeda (2000) Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473: 161-164.
25. Nakamae, A., T. Sunagawa, O. Ishida, O. Suzuki, Y. Yasunaga, H. Hachisuka, M. Ochi (2004) Acceleration of surgical angiogenesis in ne-crotic bone with a single injection of fibro-blast growth factor-2 (FGF-2). J Orthop Res 22:509-513.
26. Nillesen, S.T., P.J. Geutjes, R. Wismans, J. Schalk-wijk, W.F. van Daamen, T.H. Kuppevelt (2007) Increased angiogenesis and blood vessel maturation in acellular collagen-hep-arin scaffolds containing both FGF2 and VEGF. Biomaterials 28: 1123-1131.
27. O'Brien, F.J., B.A. Harley, I.V. Yannas, L.J. Gibson (2005) The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 26: 433-441.
28. Ooms, E.M., J.G. Wolke, J.P. van der Waerden, J.A. Jansen (2002) Trabecular bone response to injectable calcium phosphate (Ca-P) cement. J Biomed Mater Res 61: 9-18.
29. Pieper, J.S., T. Hafmans, P.B. van Wachem, M.J. van Luyn, L.A. Brouwer, J.H. Veerkamp, T. H. van Kuppevelt (2002) Loading of colla-gen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 62: 185-194.
30. Rabie, A.B. (1997) Vascular endothelial growth pattern during demineralized bone matrix induced osteogenesis. Connect Tissue Res 36: 337-345.
31. Rabie, A.B., M. Lu (2004) Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor during healing of allogeneic bone graft. Arch Oral Biol 49: 1025-1033.
32. Rickert, D., M.A. Moses, A. Lendlein, S. Kelch, R.P. Franke (2003) The importance of angiogenesis in the interaction between polymeric biomaterials and surrounding tissue. Clin Hemorheol Microcirc 28: 175-181.
33. Ruhe, P.Q., H.C. Kroese-Deutman, J.G. Wolke, P.H. Spauwen, J.A. Jansen (2004) Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials 25: 2123-2132.
34. Schlageter, K.E., P. Molnar, G.D. Lapin, D.R. Groothuis (1999) Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Micro-vasc Res 58: 312-328.
35. Spyridopoulos, I., E. Brogi, M. Kearney, A.B. Sullivan, C. Cetrulo, J.M. Isner, D.W. Losor-do (1997) Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J Mol Cell Cardiol 29: 1321-1330.
36. Tamai, N., A. Myoui, T. Tomita, T. Nakase, J. Tanaka, T. Ochi, H. Yoshikawa (2002) Novel hydroxyapatite ceramics with an intercon-nective porous structure exhibit superior os-teoconduction in vivo. J Biomed Mater Res 59: 110-117.
37. Xu, S., D. Li, C. Wang, Z. Wang, B. Lu (2007) Cell proliferation in CPC scaffold with a central channel. Biomed Mater Eng 17: 1-8.
38. Zisch, A.H., U. Schenk, J.C. Schense, S.E. Saki-yama-Elbert, J.A. Hubbell (2001) Covalently conjugated VEGF-fibrin matrices for en-dothelialization. J Control Release 72: 101-113.